MEDIA
All Media
PNOC Foundation’s Bold Vision to Accelerate Research for the Deadliest Childhood Cancers
PNOC Foundation celebrates the launch of PNOC035, a groundbreaking clinical trial for children, adolescents, and young adults with recurrent or progressive atypical teratoid rhabdoid tumor (ATRT).
The New York Times: For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough, July 16, 2026
Biopharma leader and longtime PNOC collaborator Jeremy Bender, brings firsthand experience turning pediatric brain cancer research into approved treatments.
Your United Airlines miles could help the world’s leading pediatric brain tumor experts collaborate on lifesaving treatments for the deadliest childhood cancers.
PNOC Foundation Wins Modern Luxury San Francisco, 2026 Philanthropy Awards, Compassion in Action
The Pediatric Neuro-Oncology Consortium (PNOC) is honored to announce an additional $50,000 gift from the Max Pound Foundation, continuing and expanding the foundation’s longstanding commitment to accelerating progress for children with brain cancer.
Michael Strahan’s Daughter Isabella Celebrates Major Milestone After Revealing New Career Shift
PNOC Foundation announces the launch of their Lose No Child: a $50 million campaign to accelerate progress against pediatric brain cancer.
FDA grants accelerated approval to dordaviprone (Modeyso, Jazz Pharmaceuticals, Inc.), a protease activator, for adult and pediatric patients 1 year of age and older with diffuse midline glioma harboring an H3 K27M mutation with progressive disease following prior therapy.
Clinical Cancer Research Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005, August, 2025
PNOC Partnership Receives Prestigious ARPA-H Multi-Million Dollar Grant for Groundbreaking RADIANT Project, to Rapidly Advance Treatments for Children With Brain Tumors
PNOC Foundation announces FDA approval of tovorafenib (day101) in partnership with pnoc scientific consortium and day one biopharmaceuticals
Rational combination platform trial design for children and young adults with diffuse midline glioma
Bay Area Doctor Leads Global Collaboration to Accelerate Cures for the Deadliest Childhood Cancer
Press Releases
PNOC Foundation celebrates the launch of PNOC035, a groundbreaking clinical trial for children, adolescents, and young adults with recurrent or progressive atypical teratoid rhabdoid tumor (ATRT).
Biopharma leader and longtime PNOC collaborator Jeremy Bender, brings firsthand experience turning pediatric brain cancer research into approved treatments.
Your United Airlines miles could help the world’s leading pediatric brain tumor experts collaborate on lifesaving treatments for the deadliest childhood cancers.
The Pediatric Neuro-Oncology Consortium (PNOC) is honored to announce an additional $50,000 gift from the Max Pound Foundation, continuing and expanding the foundation’s longstanding commitment to accelerating progress for children with brain cancer.
PNOC Partnership Receives Prestigious ARPA-H Multi-Million Dollar Grant for Groundbreaking RADIANT Project, to Rapidly Advance Treatments for Children With Brain Tumors
PNOC Foundation announces FDA approval of tovorafenib (day101) in partnership with pnoc scientific consortium and day one biopharmaceuticals
Rational combination platform trial design for children and young adults with diffuse midline glioma
PNOC In the News
PNOC Foundation’s Bold Vision to Accelerate Research for the Deadliest Childhood Cancers
The New York Times: For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough, July 16, 2026
PNOC Foundation Wins Modern Luxury San Francisco, 2026 Philanthropy Awards, Compassion in Action
Michael Strahan’s Daughter Isabella Celebrates Major Milestone After Revealing New Career Shift
Bay Area Doctor Leads Global Collaboration to Accelerate Cures for the Deadliest Childhood Cancer
Scientific Publications
PNOC Foundation’s Bold Vision to Accelerate Research for the Deadliest Childhood Cancers
The New York Times: For Families Facing a Deadly Brain Cancer, Scientific Progress Can’t Come Soon Enough, July 16, 2026
PNOC Foundation Wins Modern Luxury San Francisco, 2026 Philanthropy Awards, Compassion in Action
Michael Strahan’s Daughter Isabella Celebrates Major Milestone After Revealing New Career Shift
Bay Area Doctor Leads Global Collaboration to Accelerate Cures for the Deadliest Childhood Cancer